
International Myeloma Foundation
@imfmyeloma
The IMF celebrates 35 years of defying boundaries & redefining possibilities! Join us as we share milestones & reflect on our #myeloma journey.
#IMF35
ID: 34340707
http://myeloma.org 22-04-2009 17:47:09
17,17K Tweet
16,16K Followers
4,4K Following


Bispecific antibodies work very effectively to treat myeloma, but they also increase the risk of infection, explains IMF CMO Dr. Joseph Mikhael. This episode of Myeloma Made Simple is supported by @Pfizer; watch the full video now at myeloma.org/node/11751 #MyelomaMadeSimple

How much weightlifting is advisable for myeloma patients? IMF Chief Medical Officer Joseph Mikhael answers in this short clip. Watch the full patient Q&A video with multiple myeloma specialist Dr. Mikhael here: myeloma.org/node/11744

Is the current climate of potential governmental cuts in science and research affecting research for myeloma? Joseph Mikhael, IMF Chief Medical Officer, shares his take on this complicated topic. Watch the full Q&A video with Dr. Mikhael here: myeloma.org/node/11744

IMF CMO Dr. Joseph Mikhael breaks down the four ways we manage the potential for infections when treating a patient with bispecific antibodies. This episode of #Myeloma Made Simple is supported by @Pfizer; watch the full video now at myeloma.org/node/11751 #MyelomaMadeSimple

Did you know immunoglobulin = antibodies? On this episode of Myeloma Made Simple, IMF CMO Joseph Mikhael breaks down how to reduce risk with bispecific antibodies. This episode is supported by @Pfizer; watch the full video now at myeloma.org/node/11751 #MyelomaMadeSimple

Once someone's been treated for several weeks with bispecific antibodies, we can sometimes back off a bit, explains IMF CMO Joseph Mikhael. This episode of Myeloma Made Simple is supported by @Pfizer; watch the full video now at myeloma.org/node/11751 #MyelomaMadeSimple


Should myeloma patients start with 2, 3, or 4 drugs? In this #IMFMyelomaMadeSimple episode, Dr. Joseph Mikhael breaks down why quadruplet therapy (4 drug combination therapy) is now the new standard of care for treating newly diagnosed multiple myeloma. myeloma.org/node/11758



We at the IMF are always here for you! Call us at the InfoLine myeloma.org/infoline, visit myeloma.org to ask our myeloma chatbot Myelo your questions day & night, and watch the full video on quadruplets w/ Joseph Mikhael myeloma.org/node/11758 #IMFMyelomaMadeSimple



Frontline therapy for multiple myeloma has changed a lot in the past year. Watch the full video on quadruplet therapy with IMF Chief Medical Officer Joseph Mikhael at myeloma.org/node/11758 Supported by an educational grant from Janssen Biotech, Inc. #IMFMyelomaMadeSimple

What have clinical trials shown about how frontline therapy should work? Watch the full video on quadruplet therapy with IMF CMO Joseph Mikhael at myeloma.org/node/11758 to find out! #IMFMyelomaMadeSimple Supported by an educational grant from Janssen Biotech, Inc.


The new standard of care in #multiplemyeloma is giving 4 drug therapy, shares IMF Chief Medical Officer Joseph Mikhael. Find out why: myeloma.org/node/11758 #IMFMyelomaMadeSimple Supported by an educational grant from Janssen Biotech, Inc. #mmsm


